# Extended LH Administration

> **NCT06883890** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Azienda Ospedaliero-Universitaria di Modena** · enrollment: 84 (estimated)

## Conditions studied

- Ovarian Reserve

## Interventions

- **DRUG:** Recombinant LH (Luveris)
- **DRUG:** No Treatment Added

## Key facts

- **NCT ID:** NCT06883890
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Modena
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06883890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06883890, "Extended LH Administration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06883890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*